GTBP

Companies
NASDAQ
Gt Biopharma Inc.
Health Care
Price Chart
Overview

About GTBP

using our proprietary platform technology, gt biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary nk cell engager (trike) platform technology. (nasdaq: gtbp)

Market Cap
$6.8M
Volume
47.8K
Avg. Volume
2.8M
P/E Ratio
-0.21018519
Dividend Yield
0.00%
Employees
2.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.68
Low Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for GTBP.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, GTBP shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$6.8M
Volume47.8K
P/E Ratio-0.21
Dividend Yield0.00%
Important Dates
Next Dividend
August 21, 2017
Next Earnings
May 14, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how GTBP fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025